A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score.
S Barbar, F Noventa, V Rossetto...
https://pubmed.ncbi.nlm.nih.gov/20738765/Actively Recruiting
Led by Al-Nahrain University · Updated on 2026-09-17
150
Participants Needed
1
Research Sites
2 weeks
Total Duration
This observational study focuses on assessing the usefulness of the Padua Prediction Score PPS for predicting the risk of venous thromboembolism VTE in patients undergoing thoracic surgery. VTE, which includes deep vein thrombosis DVT and pulmonary embolism PE, is a significant cause of illness and death, especially in hospitalized patients who may have prolonged immobility or other risk factors. The study aims to determine if the PPS can more accurately predict VTE risk in the setting of Iraqi healthcare, where local data are limited. Participants will have their VTE risk evaluated using the Padua Prediction Score during hospital admission, specifically one day before surgery. The study will observe patients during their hospital stay, which typically lasts around 10 days, and continue follow-up after discharge on days 7, 15, and 30. No active treatment or intervention is given, as the study monitors how well the PPS predicts VTE outcomes in routine care. Throughout the study, participants will be monitored for episodes of VTE, including symptomatic pulmonary embolism and recurrent DVT. Assessments will include clinical evaluations and laboratory tests such as postoperative D-dimer tests. Follow-up visits after discharge will help capture any late events or complications. The study involvement lasts through hospital admission and up to 30 days post-discharge to collect comprehensive outcome data.
CONDITIONS
Padua Prediction Score for VTE Risk in Thoracic Surgery Patients
A
Abdul-Ilah R. Khamis
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Al-Nahrain University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 10 days
Participants have their venous thromboembolism risk evaluated using the Padua Prediction Score one day before surgery and are monitored during their hospital stay.
Daily assessments during hospital stay
Duration - 30 days after discharge
Participants are followed up after hospital discharge on days 7, 15, and 30 to monitor for venous thromboembolism events and related complications.
3 follow-up visits
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
S Barbar, F Noventa, V Rossetto...
https://pubmed.ncbi.nlm.nih.gov/20738765/Majed S Al Yami, Matthew A Silva, Jennifer L Donovan...
https://pubmed.ncbi.nlm.nih.gov/29043538/Al-Nahrain University
Lead Sponsor